Literature DB >> 30061394

Cellular clearance of circulating transthyretin decreases cell-nonautonomous proteotoxicity in Caenorhabditis elegans.

Kayalvizhi Madhivanan1,2,3, Erin R Greiner1,2,3, Miguel Alves-Ferreira1,2,3,4,5,6, David Soriano-Castell1,2,3, Nirvan Rouzbeh1,2,3, Carlos A Aguirre1,2,3, Johan F Paulsson1, Justin Chapman7, Xin Jiang7, Felicia K Ooi8, Carolina Lemos4,5,6, Andrew Dillin9,10, Veena Prahlad8, Jeffery W Kelly1,11,12, Sandra E Encalada13,2,3.   

Abstract

Cell-autonomous and cell-nonautonomous mechanisms of neurodegeneration appear to occur in the proteinopathies, including Alzheimer's and Parkinson's diseases. However, how neuronal toxicity is generated from misfolding-prone proteins secreted by nonneuronal tissues and whether modulating protein aggregate levels at distal locales affects the degeneration of postmitotic neurons remains unknown. We generated and characterized animal models of the transthyretin (TTR) amyloidoses that faithfully recapitulate cell-nonautonomous neuronal proteotoxicity by expressing human TTR in the Caenorhabditis elegans muscle. We identified sensory neurons with affected morphological and behavioral nociception-sensing impairments. Nonnative TTR oligomer load and neurotoxicity increased following inhibition of TTR degradation in distal macrophage-like nonaffected cells. Moreover, reducing TTR levels by RNAi or by kinetically stabilizing natively folded TTR pharmacologically decreased TTR aggregate load and attenuated neuronal dysfunction. These findings reveal a critical role for in trans modulation of aggregation-prone degradation that directly affects postmitotic tissue degeneration observed in the proteinopathies.

Entities:  

Keywords:  aggregation; cell-nonautonomous; neurodegeneration; nonnative oligomers; polyneuropathy

Mesh:

Substances:

Year:  2018        PMID: 30061394      PMCID: PMC6099907          DOI: 10.1073/pnas.1801117115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  70 in total

1.  Aromatic sulfonyl fluorides covalently kinetically stabilize transthyretin to prevent amyloidogenesis while affording a fluorescent conjugate.

Authors:  Neil P Grimster; Stephen Connelly; Aleksandra Baranczak; Jiajia Dong; Larissa B Krasnova; K Barry Sharpless; Evan T Powers; Ian A Wilson; Jeffery W Kelly
Journal:  J Am Chem Soc       Date:  2013-02-14       Impact factor: 15.419

2.  Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30).

Authors:  G Holmgren; L Steen; J Ekstedt; C G Groth; B G Ericzon; S Eriksson; O Andersen; I Karlberg; G Nordén; M Nakazato
Journal:  Clin Genet       Date:  1991-09       Impact factor: 4.438

3.  Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein.

Authors:  H L Monaco; M Rizzi; A Coda
Journal:  Science       Date:  1995-05-19       Impact factor: 47.728

4.  Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 A.

Authors:  C C Blake; M J Geisow; S J Oatley; B Rérat; C Rérat
Journal:  J Mol Biol       Date:  1978-05-25       Impact factor: 5.469

5.  Developmental genetics of the mechanosensory neurons of Caenorhabditis elegans.

Authors:  M Chalfie; J Sulston
Journal:  Dev Biol       Date:  1981-03       Impact factor: 3.582

6.  The cell-non-autonomous nature of electron transport chain-mediated longevity.

Authors:  Jenni Durieux; Suzanne Wolff; Andrew Dillin
Journal:  Cell       Date:  2011-01-07       Impact factor: 41.582

7.  Investigating the spreading and toxicity of prion-like proteins using the metazoan model organism C. elegans.

Authors:  Carmen I Nussbaum-Krammer; Mário F Neto; Renée M Brielmann; Jesper S Pedersen; Richard I Morimoto
Journal:  J Vis Exp       Date:  2015-01-08       Impact factor: 1.355

Review 8.  Targeting protein aggregation for the treatment of degenerative diseases.

Authors:  Yvonne S Eisele; Cecilia Monteiro; Colleen Fearns; Sandra E Encalada; R Luke Wiseman; Evan T Powers; Jeffery W Kelly
Journal:  Nat Rev Drug Discov       Date:  2015-09-04       Impact factor: 84.694

Review 9.  Prion-like mechanisms in the pathogenesis of tauopathies and synucleinopathies.

Authors:  Michel Goedert; Ben Falcon; Florence Clavaguera; Markus Tolnay
Journal:  Curr Neurol Neurosci Rep       Date:  2014-11       Impact factor: 5.081

10.  Temperature- and touch-sensitive neurons couple CNG and TRPV channel activities to control heat avoidance in Caenorhabditis elegans.

Authors:  Shu Liu; Ekkehard Schulze; Ralf Baumeister
Journal:  PLoS One       Date:  2012-03-20       Impact factor: 3.240

View more
  10 in total

Review 1.  The discovery and consequences of the central role of the nervous system in the control of protein homeostasis.

Authors:  Veena Prahlad
Journal:  J Neurogenet       Date:  2020-06-12       Impact factor: 1.250

2.  Santalol Isomers Inhibit Transthyretin Amyloidogenesis and Associated Pathologies in Caenorhabditis elegans.

Authors:  Amirthalingam Mohankumar; Duraisamy Kalaiselvi; Govindhan Thiruppathi; Sivaramakrishnan Muthusaravanan; Subramaniam Vijayakumar; Rahul Suresh; Shinkichi Tawata; Palanisamy Sundararaj
Journal:  Front Pharmacol       Date:  2022-06-16       Impact factor: 5.988

3.  Development of transgenic Caenorhabditis elegans expressing human transthyretin as a model for drug screening.

Authors:  Yukimoto Tsuda; Kunitoshi Yamanaka; Risa Toyoshima; Mitsuharu Ueda; Teruaki Masuda; Yohei Misumi; Teru Ogura; Yukio Ando
Journal:  Sci Rep       Date:  2018-12-14       Impact factor: 4.379

4.  Reducing INS-IGF1 signaling protects against non-cell autonomous vesicle rupture caused by SNCA spreading.

Authors:  Carl Alexander Sandhof; Simon Oliver Hoppe; Silke Druffel-Augustin; Christian Gallrein; Janine Kirstein; Cindy Voisine; Carmen Nussbaum-Krammer
Journal:  Autophagy       Date:  2019-07-29       Impact factor: 16.016

Review 5.  C. elegans Models to Study the Propagation of Prions and Prion-Like Proteins.

Authors:  Carl Alexander Sandhof; Simon Oliver Hoppe; Jessica Tittelmeier; Carmen Nussbaum-Krammer
Journal:  Biomolecules       Date:  2020-08-15

Review 6.  Amyloid Formation by Globular Proteins: The Need to Narrow the Gap Between in Vitro and in Vivo Mechanisms.

Authors:  Giulia Faravelli; Valentina Mondani; P Patrizia Mangione; Sara Raimondi; Loredana Marchese; Francesca Lavatelli; Monica Stoppini; Alessandra Corazza; Diana Canetti; Guglielmo Verona; Laura Obici; Graham W Taylor; Julian D Gillmore; Sofia Giorgetti; Vittorio Bellotti
Journal:  Front Mol Biosci       Date:  2022-02-14

Review 7.  The Genetics of Neuropathic Pain from Model Organisms to Clinical Application.

Authors:  Margarita Calvo; Alexander J Davies; Harry L Hébert; Greg A Weir; Elissa J Chesler; Nanna B Finnerup; Roy C Levitt; Blair H Smith; G Gregory Neely; Michael Costigan; David L Bennett
Journal:  Neuron       Date:  2019-11-20       Impact factor: 17.173

8.  C. elegans expressing D76N β2-microglobulin: a model for in vivo screening of drug candidates targeting amyloidosis.

Authors:  Giulia Faravelli; Sara Raimondi; Loredana Marchese; Frederick A Partridge; Cristina Soria; P Patrizia Mangione; Diana Canetti; Michele Perni; Francesco A Aprile; Irene Zorzoli; Elia Di Schiavi; David A Lomas; Vittorio Bellotti; David B Sattelle; Sofia Giorgetti
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

Review 9.  Transthyretin Amyloidosis: Update on the Clinical Spectrum, Pathogenesis, and Disease-Modifying Therapies.

Authors:  Haruki Koike; Masahisa Katsuno
Journal:  Neurol Ther       Date:  2020-09-18

10.  Cu(II) Binding Increases the Soluble Toxicity of Amyloidogenic Light Chains.

Authors:  Rosaria Russo; Margherita Romeo; Tim Schulte; Martina Maritan; Luca Oberti; Maria Monica Barzago; Alberto Barbiroli; Carlo Pappone; Luigi Anastasia; Giovanni Palladini; Luisa Diomede; Stefano Ricagno
Journal:  Int J Mol Sci       Date:  2022-01-16       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.